免疫增生性疾病的临床试验
总计144583个结果
-
Novartis Pharmaceuticals完全的
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.终止
-
PIQUR Therapeutics AGCharite University, Berlin, Germany; University Hospital, Basel, Switzerland; University Hospital... 和其他合作者完全的
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.未知
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
GlaxoSmithKline完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)终止
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.终止
-
Enzon Pharmaceuticals, Inc.完全的
-
University Hospital Southampton NHS Foundation...未知
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Shandong New Time Pharmaceutical Co., LTD尚未招聘
-
Stanford UniversityCellSight Technologies, Inc.招聘中
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; First People's Hospital of Hangzhou; Ningbo Medical Center Lihuili Hospital 和其他合作者招聘中
-
Peking Union Medical College Hospital招聘中
-
Kim, Seok JinCelltrion; Samyang Biopharmaceuticals Corporation招聘中
-
Oncology Institute of Southern SwitzerlandEnte Ospedaliero Cantonale, Bellinzona; Istituto Cantonale di Patologia招聘中
-
Peking Union Medical College Hospital招聘中
-
Celgene主动,不招人
-
Bayer完全的淋巴瘤,非霍奇金台湾, 俄罗斯联邦, 巴西, 保加利亚, 大韩民国, 波兰, 意大利, 希腊, 火鸡, 南非
-
Mayo ClinicM.D. Anderson Cancer Center; Washington University School of Medicine; University of Miami; University... 和其他合作者撤销
-
Calithera Biosciences, IncNektar Therapeutics撤销
-
Millennium Pharmaceuticals, Inc.终止
-
University of California, San FranciscoNational Comprehensive Cancer Network完全的
-
Boehringer Ingelheim完全的
-
Sutphin DrugsBharath Charitable Cancer Hospital and Institute未知
-
Eli Lilly and Company完全的非霍奇金淋巴瘤美国, 中国, 西班牙, 波兰, 台湾, 比利时, 日本, 德国, 波多黎各, 澳大利亚, 法国, 瑞典, 希腊, 意大利, 印度, 捷克语, 英国, 加拿大, 大韩民国, 墨西哥, 丹麦, 葡萄牙, 芬兰, 巴西, 匈牙利